Indapta Therapeutics
Drug DiscoveryWebsite
Operator of a biotechnology company focused on developing a natural killer cell therapy with potent activity to treat cancer. The company specializes in commercializing a proprietary off-the-shelf, no...
Valuation
$0
Share Price
N/A
Total Raised
$162.3M
Last Round
Later Stage VC
Dec 2024
Latest Funding Round
Later Stage VC
Dec 17, 2024
$22.5M
raised
Investors
+11 other investors